Use access key #2 to skip to page content.
$2.41 0.02 (0.84%)
7/3/2008 1:00 PM

Cell Genesys, Inc. (CEGE)

CAPS Rating:
***

A biotechnology company focused on the development and commercialization of novel biological therapies for patients with cancer.

View All Commentary (CEGE)

Recs

0

Avatar johnnymack91362 (97.87) Submitted: 4/27/08 7:16 PM : Outperform Start Price: $3.81 CEGE Score: -27.08

value already showing with takeda investment.

Report this Post Replies: 0 | Reply

Featured Broker Partners